Natural compounds as inhibitors of SARS-CoV-2 main protease (3CLpro): A molecular docking and simulation approach to combat COVID-19

MT Rehman, MF AlAjmi… - Current pharmaceutical …, 2021 - ingentaconnect.com
Background: The emergence and dissemination of SARS-CoV-2 has caused high mortality
and enormous economic loss. Rapid development of new drug molecules is the need of …

Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from …

BK Kumar, n Faheem, KVGC Sekhar… - Journal of …, 2022 - Taylor & Francis
COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
primarily appeared in Wuhan, China, in December 2019. At present, no proper therapy and …

[HTML][HTML] Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against …

H Rai, A Barik, YP Singh, A Suresh, L Singh, G Singh… - Molecular Diversity, 2021 - Springer
The importance of the main protease (M pro) enzyme of SARS-CoV-2 in the digestion of viral
polyproteins introduces M pro as an attractive drug target for antiviral drug design. This study …

Promising inhibitors of main protease of novel corona virus to prevent the spread of COVID-19 using docking and molecular dynamics simulation

D Kumar, K Kumari, VK Vishvakarma… - Journal of …, 2021 - Taylor & Francis
Abstract Coronavirus disease-2019 (COVID-19) is a global health emergency and the matter
of serious concern, which has been declared a pandemic by WHO. Till date, no potential …

In silico identification of potent COVID-19 main protease inhibitors from FDA approved antiviral compounds and active phytochemicals through molecular docking: a …

V Chandel, S Raj, B Rathi, D Kumar - 2020 - preprints.org
The Novel Coronavirus (COVID-19) is a positive-sense single-stranded RNA ((+) ssRNA)
virus. The COVID-19 Main Proteases play very important role in the propagation of the Novel …

Potential of Plant Bioactive Compounds as SARS‐CoV‐2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study

TE Tallei, SG Tumilaar, NJ Niode, fnm Fatimawali… - …, 2020 - Wiley Online Library
Since the outbreak of the COVID‐19 (coronavirus disease 19) pandemic, researchers have
been trying to investigate several active compounds found in plants that have the potential to …

[HTML][HTML] In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2

AS Jain, P Sushma, C Dharmashekar… - Saudi Journal of …, 2021 - Elsevier
The novel coronavirus pandemic has spread over in 213 countries as of July 2020.
Approximately 12 million people have been infected so far according to the reports from …

[HTML][HTML] Several coumarin derivatives and their Pd (II) complexes as potential inhibitors of the main protease of SARS-CoV-2, an in silico approach

DA Milenković, DS Dimić, EH Avdović, ZS Marković - RSC advances, 2020 - pubs.rsc.org
The global pandemic of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
caused many fatalities among people and significantly influenced the global economy …

Dietary polyphenols mitigate SARS-CoV-2 main protease (Mpro)–Molecular dynamics, molecular mechanics, and density functional theory investigations

TI Adelusi, AQK Oyedele, OE Monday… - Journal of Molecular …, 2022 - Elsevier
The recent evolution of the SARS-like Coronavirus has ravaged the world. The deadly virus
has claimed over millions of lives across the world and hence highlights the need to develop …

[HTML][HTML] In silico evaluation of Iranian medicinal plant phytoconstituents as inhibitors against main protease and the receptor-binding domain of SARS-CoV-2

SS Mousavi, A Karami, TM Haghighi, SG Tumilaar… - Molecules, 2021 - mdpi.com
The novel coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), which initially appeared in Wuhan, China, in …